NCT06566118

Brief Summary

During the recovery process, the activity of the sympathetic system decreases, while the activity of the parasympathetic system increases. In line with this information, the nervous system can be regulated in a noninvasive and practical way by using transcutaneous auricular vagus nerve stimulation in order to achieve rapid recovery in the athlete after the activity.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 15, 2024

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 22, 2024

Completed
11 months until next milestone

Study Start

First participant enrolled

August 1, 2025

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 15, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 15, 2025

Completed
Last Updated

March 25, 2026

Status Verified

March 1, 2026

Enrollment Period

2 months

First QC Date

August 15, 2024

Last Update Submit

March 24, 2026

Conditions

Keywords

Auricular Vagus Nerve StimulationAthleteRecovery

Outcome Measures

Primary Outcomes (4)

  • Respiratory Function Test

    In our study, FVC measurement were calculated using a MiniSpir2 brand spirometer device. The measurements were performed while the participants were sitting in a fixed chair. The measurements were repeated 3 times for each participant and the two highest values read on the device were recorded as an average.

    2 Months

  • Respiratory Function Test

    In our study, FEV1/FVC measurement were calculated using a MiniSpir2 brand spirometer device. The measurements were performed while the participants were sitting in a fixed chair. The measurements were repeated 3 times for each participant and the two highest values read on the device were recorded as an average.

    2 Months

  • Respiratory Function Test

    In our study, PEF measurement were calculated using a MiniSpir2 brand spirometer device. The measurements were performed while the participants were sitting in a fixed chair. The measurements were repeated 3 times for each participant and the two highest values read on the device were recorded as an average.

    2 Months

  • Respiratory Function Test

    In our study, FEV1 measurement were calculated using a MiniSpir2 brand spirometer device. The measurements were performed while the participants were sitting in a fixed chair. The measurements were repeated 3 times for each participant and the two highest values read on the device were recorded as an average.

    2 Months

Secondary Outcomes (1)

  • BORG Perceived Fatigue Measurement

    2 Months

Other Outcomes (3)

  • Pulse Measurement

    2 Months

  • SPO2 Measurement

    2 Months

  • Blood Pressure Measurement

    2 Months

Study Arms (2)

Intervention Group

EXPERIMENTAL

Active auricular VSS was applied to the participants in Group 1 after exercise loading.

Device: Auricular Vagus Nerve Stimülation

Sham Group

SHAM COMPARATOR

Sham auricular VSS was applied to the participants in Group 2. During the application, the device was shown to the participants while it was being operated, but no current was given to the participants because non-conductive headphones were used.

Device: Sham Auricular Vagus Nerve Stimülation

Interventions

After exercise loading, active ear VSS was applied to Group 1. Application was made simultaneously in both ears, with a 300 microsecond pulse duration, a biphasic asymmetric waveform, and a frequency of 25 Hz, for a total of 20 minutes. All assessments were recorded 3 times: at the beginning of the test, after exercise loading, and after active VSS application.

Intervention Group

After the exercise challenge, Group 2 underwent sham VSS. Device parameters were set to the same as Group 1 (300 microsecond pulse duration, biphasic asymmetric waveform, and 25 Hz frequency). Both headphones were worn for a total of 20 minutes. However, the participant heard only the device's power-on tone and received no current. All assessments were recorded three times: at the beginning of the test, after the exercise challenge, and after sham VSS.

Sham Group

Eligibility Criteria

Age18 Years - 25 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Being healthy between the ages of 18-25,
  • Volunteering to participate in the study,
  • Signing the voluntary consent form,
  • Being an amateur football player who continues his/her active sports life,
  • Not having an injury that prevents participation in the study.

You may not qualify if:

  • Having a disease related to the respiratory system,
  • Having a disease related to the cardiac system,
  • Having any chronic disease and using a medication related to it.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

İstanbul Gelisim University

Istanbul, Istanbul, 34310, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Fatigue

Condition Hierarchy (Ancestors)

Signs and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • ALİ KARAAĞAÇ, MSc

    Principal Investigator

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
During the application to the group that would receive sham auricular vagus nerve stimulation, the device was shown to the participants while it was being operated, but no current was given to the participants because headphones without conductive properties were used.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Uncontrolled study with the same sample in two groups
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

August 15, 2024

First Posted

August 22, 2024

Study Start

August 1, 2025

Primary Completion

September 15, 2025

Study Completion

September 15, 2025

Last Updated

March 25, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations